Exact Sciences (NASDAQ:EXAS) Given New $70.00 Price Target at Piper Sandler
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target cut by stock analysts at Piper Sandler from $75.00 to $70.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s price objective would suggest a potential upside of 46.38% from the […]
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target cut by stock analysts at Piper Sandler from $75.00 to $70.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s price objective would suggest a potential upside of 46.38% from the […]
